Health news
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab for the treatment of adults with prurigo nodularis. The target action date for the FDA’s decision…
The Food and Drug Administration has approved Korsuva (difelikefalin) injection for the treatment of moderate to severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. Korsuva is a kappa opioid receptor agonist that…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021